Tag: Biopsy
PRECISION: MRI-targeted biopsy strategy leads to fewer men needing biopsy
A Magnetic Resonance Imaging (MRI)-targeted biopsy strategy results in fewer men needing biopsy, fewer biopsy cores required and more men with clinically significant cancer detected compared to standard transrectal ultrasound guided (TRUS) biopsy, according to the large international multicentre...
Using MRI before biopsy: A divisive topic?
Emerging technologies trigger new approaches. But with the perceived benefits of novel discoveries come the expected criticisms and contrary viewpoints. The issue of Magnetic Resonance Imaging (MRI) has prompted closer examination from both its adherents and critics during Thematic...
EAU15: State-of-the-art lectures present latest in prostate biopsy and bladder obstruction
During the state-of-the-art lectures in the eURO Auditorium, Prof. David Crawford (US) emphasised the need for a redefinition of the PSA biomarker, while Prof. Keong Tatt Foo (SG) sought to define IPP and BPH, and present the evidence for...
Are there useable molecular markers for prostate cancer?
There is no doubt that we need more and better markers to determine risk, presence, aggressiveness and therapy response of prostate cancer (PCa). Besides physical symptoms such as palpable irregularities upon digital rectal examination (DRE), current indicators range from...
9th ESOU Meeting re-examines prostate cancer issues on screening, biopsies and imaging
The issue of prostate cancer screening remains a much-discussed topic but recent studies are proving that screening decreases prostate cancer mortality, according to J. Hugosson who lectured during the three-day 9th ESOU (EAU Section of Oncological Urology) Meeting which...